SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs informs about press release

29 Apr 2025 Evaluate
Pursuant to Regulation 30 of Listing Regulations, Aarti Pharmalabs has enclosed a Press Release titled ‘Aarti Pharmalabs Earns EcoVadis Gold Rating, Among Top 5% Globally for Sustainability’. The Press Release is also available on the website of the Company i.e. www.aartipharmalabs.com

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

693.75 4.75 (0.69%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×